Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Optimal formula of urinastatin vaginal suppository and it’s clinical usefulness

  • In: Poster presentation
  • At: Seoul (South Korea) (2017)
  • Type: Poster
  • Poster code: POS-HPS-114
  • By: SATAKE, Kiyoshi (Saitama Redcloss Hospital, Hospital, saitamasi, Japan)
  • Co-author(s): Kiyoshi Satake: Department of Pharmacy, Japanese Red Cross Saitama Hospital, saitama, Japan
    Hideaki Monchusho: Department of Pharmacy, Japanese Red Cross Saitama Hospital, saitama, Japan
    Takanori Nakajima: Department of Clinical Pharmaceutics, Nihon Pharmaceutical University, saitama, Japan
    Masanori Iwata: Department of Clinical Pharmaceutics, Nihon Pharmaceutical University, saitama, Japan
    Mitsuru Machida: Department of Pharmacy, Japanese Red Cross Saitama Hospital, saitama, Japan
    Sumitaka Miyamoto: Department of Obstetrics and Gynecology, Japanese Red Cross Saitama Hospital, saitama, Japan
    Manabu Nakamura: Department of Obstetrics and Gynecology, Japanese Red Cross Saitama Hospital, saitama, Japan
    Akihiko Ando: Department of Obstetrics and Gynecology, Japanese Red Cross Saitama Hospital, saitama, Japan
  • Abstract:

    Background

    N-US">In Japan an urinastatin vaginal suppository (UVS) is used to delay impending premature birth. It is not commercially available, is prepared by pharmacist as a hospital preparation.

    Purpose

     We investigated optimized formula of UVS and its clinical usefulness.

    Methods

     (1) Preparation: An optimal prescription was examined based on the..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses